medroxyprogesterone acetate has been researched along with Postpartum Amenorrhea in 86 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 26 (30.23) | 18.7374 |
1990's | 24 (27.91) | 18.2507 |
2000's | 24 (27.91) | 29.6817 |
2010's | 9 (10.47) | 24.3611 |
2020's | 3 (3.49) | 2.80 |
Authors | Studies |
---|---|
Bahamondes, L; Brache, V; Burke, HM; Deese, J; Fuchs, R; Miller, A; Packer, C; Salinas, A; Veiga, N | 1 |
Kassahun-Yimer, W; Lutz, E; Ngwudike, C; Shwayder, J; Sims, J; Wallace, K | 1 |
Ayatiafin, S; Falahat, F; Feyzabadi, Z; Jarahi, L; Mokaberinejad, R; Rakhshandeh, H; Tavakkoli, M | 1 |
Bekhradi, R; Mohammad-Alizadeh-Charandabi, S; Mohebbi-Kian, E | 1 |
Schreiber, CA; Sober, S | 1 |
Diamond, K; Nickkho-Amiry, M; Seif, MW | 1 |
Pieh Holder, KL | 1 |
Hussein, M | 1 |
Botsis, D; Creatsas, G; Deligeoroglou, E; Makrakis, E; Papagianni, V | 1 |
Kanasaki, H; Miyazaki, K; Oride, A; Purwana, IN | 1 |
Abd Alhamid, M; Elyan, A; Ibrahim, A; Ibrahim, EA; Laban, M | 1 |
Hua, FF; Xia, YH; Yang, J | 1 |
Mcdaniel, EB | 1 |
D'arcangues, C | 1 |
Ammar, R; El-mahgoub, S; Karim, M; Yassin, S | 1 |
Asbury, EA; Collins, P; Elkington, AG; Gatehouse, PD; Hayward, CS; Kubba, A; Ong, PJ; Pennell, DJ; Sorensen, MB; Webb, CM; Yang, GZ | 1 |
Aleman Herrera, M; Baez Reyes, A; Pena Delgado, J | 1 |
Hatcher, RA; Schnare, S | 1 |
McFadyen, L; Preston-Whyte, E; Smit, J; Zuma, K | 1 |
Janaud, A | 1 |
Correu Azcona, S | 1 |
Jones, M | 1 |
El-sokkary, H; Nayel, S; Toppozada, M; Tork, M | 1 |
Molitor-peffer, MP | 1 |
Badraoui, MH; Hefnawi, F | 1 |
Liu, JH; Shumel, BS; Simon, JA; Speroff, L; Symons, JP | 1 |
Charuruks, N; Chotnopparatpattara, P; Taneepanichskul, S; Treratanachat, S | 1 |
Brooks-Gunn, J; Fox, RP; Hamilton, L; Hamilton, WG; Holderness, CC; Hyle, EP; Warren, MP | 1 |
COHEN, H; HASKINS, AL; MOSZKOWSKI, EF | 1 |
Castle, S | 1 |
Chotnopparatpattara, P; Fraser, IS; Markham, R; Russell, P; Sereepapong, W; Taneepanichskul, S | 1 |
Hata, T; Matsumoto, J | 1 |
Bode, FR; Jain, J; Jakimiuk, AJ; Kaunitz, AM; Ross, D | 1 |
Kazerooni, T; Zolghadri, J | 1 |
Arias, RD; Brucker, C; Jain, JK; Ray, A; Ross, D | 1 |
Amanati, L; Arshi, S; Eftekhar, H; Ehdaeivand, F; Sadeghi-Bazargani, H; Sezavar, H | 1 |
Soper, DE; Thurman, AR | 1 |
Heikkinen, J; Kudela, M; Mattila, L; Mattsson, LA; Mustonen, M; Rees, M; Salminen, K; Skouby, S; Stadnicki-Kolendo, A; Vuorela, A | 1 |
Bahamondes, L; Castro, S; Fernandes, A; Juliato, CT; Marchi, NM; Olivotti, B | 1 |
Laukaran, VH | 1 |
Fraser, IS | 2 |
Revaz, C | 1 |
Cabrol, S; Genel, M; Haseltine, FP; Taylor, KJ; Viscomi, G | 1 |
Jahan, FA; Khan, AR; Swenson, I | 1 |
Gershagen, S; Jeppsson, S; Johansson, ED; Rannevik, G | 1 |
Chen, JK; Chen, SF; Fang, KJ; Ge, JL; Ge, RS; He, ML; Luo, SY; Sang, GW; Shao, QX; Song, S | 1 |
Adamopoulos, PN; Aravantinos, D; Arefetz, N; Creatsas, G; Konstantellou, E | 1 |
Eden, JA | 1 |
Gastaldi, M; Genazzani, AD; Genazzani, AR; Montanini, V; Petraglia, F; Pianazzi, F; Volpogni, C | 1 |
Garceau, RJ; Jiang, S; Lei, ZW; Vander Meulen, TC; Wang, WL; Wu, SC; Yang, QZ | 1 |
Battino, S; Ben-Ami, M; Geslevich, Y; Shalev, E; Weiner, E | 1 |
Cumming, DC | 1 |
Buonocore, G; Farina, G; Gioia, D; Massafra, C; Sargentini, I | 1 |
Henderson, KA; Matson, SC; McGrath, GJ | 1 |
McGee, C | 1 |
Bahamondes, L; Diaz, J; Hall, P; Petta, C | 1 |
d'Arcangues, C; Dinchuen, P; Koetsawang, S; Patrasupapong, N; Piaggio, G; Pinol, A; Piya-Anant, M | 1 |
Fan, S; Li, B; Tang, G; Tang, OS; Yip, P | 1 |
Flanagan, PJ; Harel, Z | 1 |
Boyd, H; Hertweck, SP; Templeman, C | 1 |
Gillmer, MD; Gray, W; Rai, VS | 1 |
Ben Hmjd, R; Ben Romdhane, M; Dakhli, R; Hamzaoui, R; Lebbi, I; Mahjoub, S; Smaïli, L; Zouari, F | 1 |
Garceau, RJ; Kaunitz, AM; Wajszczuk, CJ | 1 |
Canto De Cetina, TE; Canto, P; Ordoñez Luna, M | 1 |
Archer, DF; Dorin, M; Lewis, V; Pickar, JH; Schneider, DL | 1 |
Simon, JA | 1 |
Lei, Z; Yang, D; Zhu, M | 1 |
Iha, T; Kanazawa, K; Kano, M; Moromizato, H; Nagai, Y; Nakayama, M | 1 |
Archer, DF; Bottiglioni, F; Pickar, JH | 1 |
Mastrantonio, P; Morelli, M; Noia, R; Palomba, S; Sena, T; Zullo, F | 1 |
Arruda, Mde S; Bedone, AJ; Fernandes, AM | 1 |
Alonso, MR; Gaitán, JR; Pérez Palacios, G; Rivera Damm, R; Ruiz, MR | 1 |
Fraser, DI; Hillard, TC; Pryse-Davies, J; Siddle, NC; Whitehead, MI | 1 |
Bourguet, C; Khawli, O; Leonard, MD; Makii, M; Morcos, RN; Smith, M | 1 |
Focan, C | 1 |
Brooks, PG; Serden, SP | 1 |
Autio, S; Härkönen, T; Huovinen, K; Lommi, L; Tikkanen, MJ; Varonen, S; Wilska, ML | 1 |
Ajmal, F; Benitez, IB; Kazi, A; Kiriwat, O; Koetsawang, S; Omar, K; Pretnar-Darovec, A; Said, S; Srisatayapan, Y; Wynter, HH | 2 |
Corenblum, B; Taylor, PJ | 1 |
Busca, B; Campbell, MJ; d'Arcangues, C; Farley, TM; Machin, D | 1 |
7 review(s) available for medroxyprogesterone acetate and Postpartum Amenorrhea
Article | Year |
---|---|
Postpartum contraception.
Topics: Amenorrhea; Birth Intervals; Breast Feeding; Condoms; Contraception; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate; Postpartum Period; Sterilization, Tubal; Venous Thromboembolism | 2014 |
Obesity and menstrual disorders.
Topics: Amenorrhea; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Endometrial Ablation Techniques; Endometrial Hyperplasia; Estrogens; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Medroxyprogesterone Acetate; Menorrhagia; Menstruation Disturbances; Obesity; Oligomenorrhea; Prevalence; Progestins | 2015 |
Contraception and Breastfeeding.
Topics: Amenorrhea; Breast Feeding; Contraception; Contraception, Postcoital; Contraceptives, Oral; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Lactation; Levonorgestrel; Medroxyprogesterone Acetate; Postpartum Period; Progesterone; Progestins; Time Factors | 2015 |
Contraceptive choices for lactating women: suggestions for postpartum family planning.
Topics: Amenorrhea; Breast Feeding; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Family Planning Services; Female; Humans; Intrauterine Devices; Medroxyprogesterone; Medroxyprogesterone Acetate; Postpartum Period; Pregnancy; Progestins; Spermatocidal Agents | 1981 |
Secondary amenorrhea leading to osteoporosis: incidence and prevention.
Topics: Adolescent; Adult; Algorithms; Amenorrhea; Anorexia Nervosa; Contraceptive Agents, Female; Exercise; Female; Humans; Incidence; Medroxyprogesterone Acetate; Osteoporosis; Patient Education as Topic; Risk Factors | 1997 |
Progestogens in the treatment of secondary amenorrhea.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Amenorrhea; Dydrogesterone; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Premenopause; Progesterone; Progesterone Congeners; Progestins | 1999 |
[Adjuvant hormone therapy of primary breast cancer. Review of the literature].
Topics: Amenorrhea; Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Delayed-Action Preparations; Female; Gonadotropin-Releasing Hormone; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Tamoxifen | 1991 |
34 trial(s) available for medroxyprogesterone acetate and Postpartum Amenorrhea
Article | Year |
---|---|
Acceptability of the contraceptive Sayana® Press when injected every four months: Results from a twelve-month trial in Brazil, Chile and the Dominican Republic.
Topics: Adolescent; Adult; Amenorrhea; Brazil; Chile; Contraceptive Agents, Female; Dominican Republic; Female; Humans; Injections, Subcutaneous; Medroxyprogesterone Acetate; Young Adult | 2022 |
Efficacy of a Herbal Formulation Based on
Topics: Adolescent; Adult; Amenorrhea; Female; Foeniculum; Humans; Medroxyprogesterone Acetate; Oligomenorrhea; Phytotherapy; Teas, Herbal; Treatment Outcome; Young Adult | 2020 |
Efficacy of fennel and combined oral contraceptive on depot medroxyprogesterone acetate-induced amenorrhea: a randomized placebo-controlled trial.
Topics: Adult; Amenorrhea; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Foeniculum; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menstruation; Phytotherapy; Plant Oils; Young Adult | 2014 |
[Clinical observation on treatment of premature ovarian failure patients of shen deficiency gan stagnation syndrome by combination of bushui roumu recipe and medroxyprogesterone acetate tablet HUA].
Topics: Adult; Amenorrhea; Drugs, Chinese Herbal; Female; Humans; Medroxyprogesterone Acetate; Phytotherapy; Primary Ovarian Insufficiency | 2012 |
Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance.
Topics: Adult; Amenorrhea; Brachial Artery; Delayed-Action Preparations; Endothelium, Vascular; Estradiol; Female; Humans; Magnetic Resonance Angiography; Male; Medroxyprogesterone Acetate; Middle Aged; Nitroglycerin; Reference Values; Reproducibility of Results; Time; Ultrasonography, Interventional; Vascular Diseases; Vasomotor System | 2002 |
Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
Topics: Adult; Amenorrhea; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Postmenopause; Time Factors; Uterine Hemorrhage | 2003 |
Persistent osteopenia in ballet dancers with amenorrhea and delayed menarche despite hormone therapy: a longitudinal study.
Topics: Adult; Aging; Amenorrhea; Bone Density; Bone Diseases, Metabolic; Dancing; Drug Administration Schedule; Estrogens, Conjugated (USP); Female; Humans; Longitudinal Studies; Medroxyprogesterone Acetate; Menarche; Progesterone Congeners | 2003 |
Contraceptive efficacy and safety of DMPA-SC.
Topics: Adult; Amenorrhea; Asia; Blood Pressure; Body Mass Index; Body Weight; Contraceptive Agents, Female; Europe; Female; Humans; Injections, Subcutaneous; Medroxyprogesterone Acetate; Patient Satisfaction; Pregnancy; United States; Uterine Hemorrhage | 2004 |
The comparison of bleeding patterns with high-dose and low-dose hormone replacement therapy in postmenopausal women.
Topics: Amenorrhea; Dose-Response Relationship, Drug; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follicle Stimulating Hormone; Humans; Medroxyprogesterone Acetate; Middle Aged; Placebos; Postmenopause; Time Factors; Uterine Hemorrhage | 2004 |
Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg.
Topics: Adult; Amenorrhea; Delayed-Action Preparations; Female; Humans; Injections, Intramuscular; Injections, Subcutaneous; Medroxyprogesterone Acetate; Menstrual Cycle; Uterine Hemorrhage | 2006 |
Low-dose oral contraceptive to re-induce menstrual bleeding in amenorrheic women on DMPA treatment: a randomized clinical trial.
Topics: Adult; Amenorrhea; Contraceptives, Oral; Dose-Response Relationship, Drug; Female; Humans; Medroxyprogesterone Acetate; Menstruation; Patient Compliance; Treatment Outcome | 2006 |
Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women.
Topics: Aged; Amenorrhea; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Middle Aged; Patient Satisfaction; Postmenopause; Surveys and Questionnaires; Treatment Outcome; Women's Health | 2007 |
Usefulness of FSH measurements for determining menopause in long-term users of depot medroxyprogesterone acetate over 40 years of age.
Topics: Adult; Amenorrhea; Contraceptive Agents, Female; Female; Follicle Stimulating Hormone; Humans; Medroxyprogesterone Acetate; Menopause; Postmenopause; Prospective Studies; Reference Values | 2007 |
Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report.
Topics: Adult; Amenorrhea; Clinical Trials as Topic; Contraception; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Administration Schedule; Female; Fertility; Humans; Injections; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Pregnancy | 1983 |
A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
Topics: Adult; Amenorrhea; Bangladesh; Clinical Trials as Topic; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Pregnancy; Random Allocation | 1980 |
WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
Topics: Amenorrhea; Body Weight; Clinical Trials as Topic; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; World Health Organization | 1982 |
A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given monthly by intramuscular injection to Chinese women. I. Contraceptive efficacy and sid effects.
Topics: Adolescent; Adult; Amenorrhea; Blood Pressure; Body Weight; China; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Female; Humans; Hydroxyprogesterones; Injections, Intramuscular; Medroxyprogesterone Acetate; Menstrual Cycle; Menstruation Disturbances; Norethindrone; Patient Dropouts | 1995 |
Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception.
Topics: Adolescent; Adult; Amenorrhea; Body Weight; Breast Feeding; China; Contraception; Contraceptive Agents, Female; Counseling; Female; Humans; Medroxyprogesterone Acetate; Menstruation Disturbances; Patient Compliance; Patient Dropouts; Patient Selection; Pregnancy; Progesterone Congeners; Time Factors | 1996 |
Factors associated with withdrawal bleeding after administration of oral dydrogesterone or medroxyprogesterone acetate in women with secondary amenorrhea.
Topics: Administration, Oral; Adolescent; Adult; Amenorrhea; Cohort Studies; Double-Blind Method; Dydrogesterone; Endometrium; Estrogens; Female; Humans; Lipoproteins; Medroxyprogesterone Acetate; Menstruation; Menstruation-Inducing Agents; Middle Aged; Oligomenorrhea; Patient Selection; Progesterone; Progesterone Congeners; Triglycerides; Ultrasonography | 1996 |
Effects of estradiol and medroxyprogesterone-acetate treatment on erythrocyte antioxidant enzyme activities and malondialdehyde plasma levels in amenorrhoic women.
Topics: Adult; Amenorrhea; Antioxidants; Catalase; Erythrocytes; Estradiol; Female; Glutathione Peroxidase; Humans; Malondialdehyde; Medroxyprogesterone Acetate; Superoxide Dismutase | 1997 |
Introductory study of the once-a-month, injectable contraceptive Cyclofem in Brazil, Chile, Colombia, and Peru.
Topics: Adult; Amenorrhea; Brazil; Chile; Colombia; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Life Tables; Medroxyprogesterone Acetate; Menstruation Disturbances; Patient Dropouts; Peru; Pregnancy Rate | 1997 |
Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
Topics: Adult; Amenorrhea; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Drug Combinations; Estradiol; Female; Follow-Up Studies; Humans; Incidence; Medroxyprogesterone Acetate; Patient Dropouts; Progesterone Congeners; Time Factors; Uterine Hemorrhage | 1998 |
Is endometrial pre-treatment of value in improving the outcome of transcervical resection of the endometrium?
Topics: Amenorrhea; Danazol; Endometrium; Estrogen Antagonists; Female; Hormones; Humans; Medroxyprogesterone Acetate; Menorrhagia; Nafarelin; Patient Satisfaction; Premedication; Prospective Studies; Treatment Outcome; Uterine Hemorrhage | 2000 |
Bleeding patterns of women using Lunelle monthly contraceptive injections (medroxyprogesterone acetate and estradiol cypionate injectable suspension) compared with those of women using Ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol triphasic) or other
Topics: Adolescent; Adult; Amenorrhea; Body Weight; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Estradiol; Female; Humans; Medroxyprogesterone Acetate; Mestranol; Middle Aged; Norethindrone; Patient Compliance; Uterine Hemorrhage | 2000 |
Effect of counseling to improve compliance in Mexican women receiving depot-medroxyprogesterone acetate.
Topics: Adult; Amenorrhea; Contraceptive Agents, Female; Counseling; Female; Humans; Medroxyprogesterone Acetate; Menstruation Disturbances; Mexico; Patient Compliance; Patient Dropouts; Patient Education as Topic | 2001 |
Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding.
Topics: Amenorrhea; Animals; Cohort Studies; Double-Blind Method; Endometrium; Estrogens, Conjugated (USP); Female; Horses; Humans; Medroxyprogesterone Acetate; Treatment Outcome; Uterine Hemorrhage | 2001 |
Amenorrhea frequency with continuous combined hormone replacement therapy: a retrospective analysis. Menopause Study Group.
Topics: Amenorrhea; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Prospective Studies; Retrospective Studies; Uterine Hemorrhage | 1998 |
Effect of different doses of progestin on uterine leiomyomas in postmenopausal women.
Topics: Amenorrhea; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Medroxyprogesterone Acetate; Postmenopause; Ultrasonography; Uterine Hemorrhage; Uterine Neoplasms | 2002 |
Serum lipids and lipoproteins during therapeutic amenorrhea induced by lynestrenol and depot-medroxyprogesterone acetate.
Topics: Adult; Amenorrhea; Apolipoprotein A-I; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Delayed-Action Preparations; Female; Humans; Intellectual Disability; Lipids; Lipoproteins; Lynestrenol; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Triglycerides | 1991 |
A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection. II. The comparison of bleeding patterns. World Health Organization Task Force on Long-Acting Systemic Agents for Fertility
Topics: Amenorrhea; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Multicenter Studies as Topic; Norethindrone; Randomized Controlled Trials as Topic | 1989 |
A multicentred phase III comparative study of two hormonal contraceptive preparations given once-a-month by intramuscular injection: I. Contraceptive efficacy and side effects. World Health Organization. Task Force on Long-Acting Systemic Agents for Ferti
Topics: Adult; Amenorrhea; Blood Pressure; Body Weight; Clinical Trials as Topic; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Patient Compliance; Pregnancy; Random Allocation | 1988 |
A multicentred phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: 1. Contraceptive efficacy and side effects. World Health Organization Task Force on Long-Acting Systemic Agents for
Topics: Adult; Amenorrhea; Blood Pressure; Body Weight; Clinical Trials as Topic; Contraceptive Agents, Female; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy; Random Allocation | 1986 |
A multicentered phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: II. The comparison of bleeding patterns. World Health Organization. Task Force on Long-Acting Systemic Agents for F
Topics: Amenorrhea; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Patient Compliance; Uterine Hemorrhage | 1987 |
Assessing changes in vaginal bleeding patterns in contracepting women.
Topics: Amenorrhea; Clinical Trials as Topic; Female; Humans; Medical Records; Medroxyprogesterone; Medroxyprogesterone Acetate; Patient Compliance; Random Allocation; Statistics as Topic | 1988 |
45 other study(ies) available for medroxyprogesterone acetate and Postpartum Amenorrhea
Article | Year |
---|---|
Depo-medroxyprogesterone acetate, weight gain and amenorrhea among obese adolescent and adult women.
Topics: Adolescent; Adult; Age Factors; Amenorrhea; Body Mass Index; Contraceptive Agents, Female; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Obesity; Retrospective Studies; Time Factors; Weight Gain; Young Adult | 2020 |
Transvaginal Doppler sonography for evaluation of irregular uterine bleeding with DMPA.
Topics: Adult; Amenorrhea; Contraceptive Agents, Female; Endometrium; Endosonography; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Metrorrhagia; Regional Blood Flow; Ultrasonography, Doppler, Color | 2011 |
Response to hormonal treatment of young females with primary or very premature ovarian failure.
Topics: Adolescent; Amenorrhea; Bone Density; Cholesterol, HDL; Estrogens; Estrogens, Conjugated (USP); Female; Gonadal Dysgenesis, 46,XY; Humans; Medroxyprogesterone Acetate; Primary Ovarian Insufficiency; Turner Syndrome; Young Adult | 2011 |
Successful pregnancy after the treatment of primary amenorrhea in a patient with non-classical congenital adrenal hyperplasia.
Topics: Adrenal Hyperplasia, Congenital; Adult; Amenorrhea; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Hirsutism; Humans; Hydrocortisone; Infant, Newborn; Medroxyprogesterone Acetate; Ovulation Induction; Pregnancy; Pregnancy Outcome; Treatment Outcome | 2013 |
Endometrial histopathology, ovarian changes and bleeding patterns among users of long-acting progestin-only contraceptives in Egypt.
Topics: Adult; Amenorrhea; Contraceptive Agents, Female; Desogestrel; Dose-Response Relationship, Drug; Egypt; Endometrium; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Ovarian Follicle; Progestins; Time Factors; Ultrasonography | 2012 |
Extracts from the report on the Joint IGCC/IFRP East and South East Asia Seminar on Regional Fertility Research.
Topics: Amenorrhea; Asia; Asia, Eastern; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Developing Countries; Disease; Evaluation Studies as Topic; Family Planning Services; Hemorrhage; Injections; Medroxyprogesterone Acetate; Menstruation Disturbances; Metrorrhagia; Patient Acceptance of Health Care; Signs and Symptoms | 1980 |
Once-a-month estrogen/progestogen injectables.
Topics: Amenorrhea; Asia; Asia, Eastern; Biology; Blood; Blood Coagulation; Carbohydrates; China; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Developing Countries; Disease; Endocrine System; Endometrium; Family Planning Services; Fibrinolysis; Genitalia; Genitalia, Female; Glucose; Hemorrhage; Hormones; Injections; International Agencies; Lipids; Medroxyprogesterone Acetate; Megestrol Acetate; Menstruation Disturbances; Metabolism; Norethindrone; Organizations; Ovulation; Patient Acceptance of Health Care; Physiology; Progesterone; Progestins; Reproduction; Research; Signs and Symptoms; United Nations; Urogenital System; Uterus; World Health Organization | 1991 |
Ovarian morphological changes with injectable contraceptives and their relation to cycle control.
Topics: Amenorrhea; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Corpus Luteum; Disease; Endometrium; Family Planning Services; Genitalia; Genitalia, Female; Histology; Injections; Medroxyprogesterone Acetate; Menstrual Cycle; Menstruation Disturbances; Norethindrone; Ovary; Ovulation; Physiology; Research; Urogenital System; Uterus; Vagina; Vaginitis | 1971 |
[Prolonged use of medroxyprogesterone acetate for contraception].
Topics: Acne Vulgaris; Amenorrhea; Americas; Behavior; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Demography; Dermatitis; Developing Countries; Disease; Family Planning Services; Health Planning; Injections; Latin America; Longitudinal Studies; Medroxyprogesterone Acetate; Menstruation Disturbances; Mexico; North America; Patient Acceptance of Health Care; Population; Population Dynamics; Reproductive Control Agents; Research; Sexual Behavior; Time; Time Factors | 1981 |
Ask the experts: progestin-only contraceptives.
Topics: Age Factors; Amenorrhea; Americas; Appetite; Biology; Body Weight; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Data Collection; Demography; Developed Countries; Disease; Drug Interactions; Family Planning Services; Hypersensitivity; Interviews as Topic; Medroxyprogesterone Acetate; Menstruation Disturbances; North America; Pharmaceutical Preparations; Physiology; Population; Population Characteristics; Progesterone Congeners; Research; Signs and Symptoms; Therapeutics; United States | 1993 |
Vaginal wetness: an underestimated problem experienced by progestogen injectable contraceptive users in South Africa.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Cross-Sectional Studies; Family Characteristics; Female; Focus Groups; Health Knowledge, Attitudes, Practice; Humans; Injections, Intramuscular; Interviews as Topic; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Qualitative Research; Rural Population; Sexual Partners; South Africa; Vaginal Discharge | 2002 |
[Depo-provera as a long-term contraceptive].
Topics: Amenorrhea; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Family Planning Services; Hemorrhage; Infertility; Injections; Medroxyprogesterone Acetate; Menstruation Disturbances; Metrorrhagia; Research; Signs and Symptoms | 1974 |
Three-monthly Depo-Provera in Mexico.
Topics: Amenorrhea; Appetite; Central Nervous System; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Digestive System; Disease; Evaluation Studies as Topic; Family Planning Services; Hemorrhage; Injections; Medroxyprogesterone Acetate; Menstruation Disturbances; Metrorrhagia; Research; Signs and Symptoms | 1977 |
Depo-Provera: just another contraceptive?
Topics: Amenorrhea; Americas; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Disease; England; Europe; Evaluation Studies as Topic; Family Planning Services; Hemorrhage; Injections; Legislation as Topic; Medroxyprogesterone Acetate; Menstruation Disturbances; Metrorrhagia; Neoplasms; North America; Signs and Symptoms; United Kingdom; United States | 1978 |
Management of amenorrhea due to contraceptive injectables by temporary IUD insertion.
Topics: Age Factors; Amenorrhea; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Diagnosis; Disease; Family Planning Services; Hemorrhage; Injections; Intrauterine Devices; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Patient Acceptance of Health Care; Retention, Psychology; Therapeutics | 1982 |
[Indications and medical survey of long acting progestatives used for contraception (author's transl)].
Topics: Amenorrhea; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Family Planning Services; Injections; Medroxyprogesterone Acetate; Norethindrone; Psychology; Reproductive Control Agents | 1982 |
Ovarian function during lactation.
Topics: Amenorrhea; Breast Feeding; Contraception; Contraceptives, Postcoital; Demography; Disease; Family Planning Services; Health; Hormones; Infant Mortality; Infant Nutritional Physiological Phenomena; Injections; Lactation; Maternal Age; Medroxyprogesterone Acetate; Menstrual Cycle; Menstruation; Nutritional Physiological Phenomena; Ovulation; Ovulation Detection; Parity; Population; Population Dynamics; Postpartum Period; Pregnancy; Puerperal Disorders; Reproduction; Time Factors | 1982 |
Relationship between progesterone receptor level in endometrium and bleeding pattern in depot medroxyprogesterone acetate users.
Topics: Adult; Amenorrhea; Biomarkers; Case-Control Studies; Cohort Studies; Contraceptive Agents, Female; Endometrium; Female; Humans; Incidence; Medroxyprogesterone Acetate; Probability; Progesterone; Reference Values; Risk Assessment; Sensitivity and Specificity; Uterine Hemorrhage | 2003 |
CHIARI-FROMMEL SYNDROME: MEDROXYPROGESTERONE ACETATE THERAPY.
Topics: Amenorrhea; Chiari-Frommel Syndrome; Female; Humans; Lactation Disorders; Medroxyprogesterone; Medroxyprogesterone Acetate; Pituitary Hormones; Pituitary Hormones, Anterior | 1964 |
Factors influencing young Malians' reluctance to use hormonal contraceptives.
Topics: Adolescent; Adolescent Behavior; Adult; Amenorrhea; Attitude of Health Personnel; Condoms; Contraception; Contraception Behavior; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Female; Health Knowledge, Attitudes, Practice; Humans; Infertility; Injections; Interviews as Topic; Male; Mali; Medroxyprogesterone Acetate; Menstruation | 2003 |
Endometrial progesterone and estrogen receptors and bleeding disturbances in depot medroxyprogesterone acetate users.
Topics: Adult; Amenorrhea; Case-Control Studies; Contraceptive Agents, Female; Delayed-Action Preparations; Endometrium; Female; Humans; Medroxyprogesterone Acetate; Receptors, Estrogen; Receptors, Progesterone; Stromal Cells; Uterine Hemorrhage | 2004 |
Re-evaluation of secondary amenorrheic patients one year after initial diagnosis: a prospective study.
Topics: Adolescent; Adult; Amenorrhea; Anovulation; Contraceptives, Oral; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Hyperprolactinemia; Hypogonadism; Medroxyprogesterone Acetate; Prospective Studies; Time Factors | 2004 |
Endometrial histology of Depomedroxyprogesterone acetate users: a pilot study.
Topics: Adult; Amenorrhea; Contraceptive Agents, Female; Endometritis; Endometrium; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Pilot Projects; Uterine Hemorrhage | 2006 |
A survey of different approaches to management of menstrual disturbances in women using injectable contraceptives.
Topics: Amenorrhea; Contraceptive Agents, Female; Curettage; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menorrhagia; Menstruation Disturbances; Norethindrone; Oligomenorrhea | 1983 |
[Real and false risks of injectable hormonal contraception].
Topics: Abnormalities, Drug-Induced; Amenorrhea; Contraceptive Agents, Female; Female; Humans; Infant, Newborn; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Pregnancy; Risk | 1984 |
Ultrasound examination of pubertal girls and of patients with gonadal dysgenesis.
Topics: Adolescent; Adult; Amenorrhea; Child; Delayed-Action Preparations; Diagnosis, Differential; Estrogens, Conjugated (USP); Female; Gonadal Dysgenesis; Humans; Hypogonadism; Hypothalamic Diseases; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Puberty; Ultrasonography; Uterus; XYY Karyotype | 1981 |
Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent.
Topics: Adult; Amenorrhea; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Female; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Progesterone; Prolactin; Sex Hormone-Binding Globulin; Time Factors | 1982 |
Transdermal estradiol plus oral medroxyprogesterone acetate replacement therapy in primary amenorrheic adolescents. Clinical, hormonal and metabolic aspects.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Amenorrhea; Bone Density; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Gonadal Dysgenesis; Humans; Lipids; Luteinizing Hormone; Medroxyprogesterone Acetate; Prolactin | 1994 |
Menopause before 40--premature, but not always permanent.
Topics: Adult; Amenorrhea; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause, Premature; Treatment Outcome | 1993 |
Modulatory role of estrogens and progestins on growth hormone episodic release in women with hypothalamic amenorrhea.
Topics: Amenorrhea; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Follicular Phase; Growth Hormone; Humans; Hypothalamic Diseases; Luteal Phase; Medroxyprogesterone Acetate; Progestins | 1993 |
Exercise-associated amenorrhea, low bone density, and estrogen replacement therapy.
Topics: Adult; Amenorrhea; Bone Density; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Exercise; Female; Humans; Medroxyprogesterone Acetate; Retrospective Studies | 1996 |
Physical findings and symptoms of depot medroxyprogesterone acetate use in adolescent females.
Topics: Adolescent; Amenorrhea; Black or African American; Contraceptive Agents, Female; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Patient Satisfaction; Pregnancy; Prospective Studies; Statistics, Nonparametric; Surveys and Questionnaires; Weight Gain | 1997 |
Long-term depot-medroxyprogesterone acetate and bone mineral density.
Topics: Absorptiometry, Photon; Adult; Age Factors; Amenorrhea; Body Mass Index; Bone Density; Bone Resorption; Calcium; Case-Control Studies; China; Contraceptive Agents, Female; Female; Femur; Humans; Lumbar Vertebrae; Medroxyprogesterone Acetate; Middle Aged; Regression Analysis; Surveys and Questionnaires | 1999 |
Pseudocyesis in an adolescent using the long-acting contraceptive Depo-Provera.
Topics: Adolescent; Amenorrhea; Contraceptive Agents, Female; Female; Humans; Medroxyprogesterone Acetate; Posture; Pregnancy; Pseudopregnancy; Spine | 1999 |
Depomedroxyprogesterone acetate use and weight gain among adolescents.
Topics: Adolescent; Amenorrhea; Analysis of Variance; Body Mass Index; Contraceptive Agents, Female; Female; Humans; Medroxyprogesterone Acetate; Retrospective Studies; Statistics, Nonparametric; Weight Gain | 2000 |
[Contraception with Depo-Provera. Report of a series of 930 women].
Topics: Abortion, Induced; Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Female; Humans; Longitudinal Studies; Medroxyprogesterone Acetate; Menstrual Cycle; Middle Aged; Patient Compliance; Retrospective Studies | 2000 |
[Evaluation of safety in Chinese women with amenorrhea following injection of depot-medroxyprogesterone for contraception].
Topics: Adult; Amenorrhea; Contraceptive Agents, Female; Estradiol; Female; Follicle Stimulating Hormone; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Vagina | 1999 |
Restoration of menstruation after chemotherapy-induced amenorrhoea in a patient with ovarian immature teratoma.
Topics: Adult; Amenorrhea; Antineoplastic Agents; Estrogens; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone Acetate; Menstruation; Ovarian Neoplasms; Ovary; Teratoma | 2001 |
Twin gestation two years after the diagnosis of premature ovarian failure in a woman on hormone replacement therapy. A case report.
Topics: Adult; Amenorrhea; Biopsy; Chorionic Gonadotropin; Diagnosis, Differential; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Outcome; Primary Ovarian Insufficiency; Twins; Ultrasonography, Prenatal | 2002 |
[Physiopathology of amenorrhea caused by medroxyprogesterone acetate].
Topics: Adult; Amenorrhea; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnanediol | 1977 |
Continuous combined conjugated equine estrogen-progestogen therapy: effects of medroxyprogesterone acetate and norethindrone acetate on bleeding patterns and endometrial histologic diagnosis.
Topics: Amenorrhea; Atrophy; Drug Therapy, Combination; Endometrium; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Time Factors; Uterine Hemorrhage | 1992 |
Vaginosonographic measurement of endometrial thickness in the evaluation of amenorrhea.
Topics: Adult; Amenorrhea; Anovulation; Contraceptive Agents, Female; Endometrium; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Ovarian Diseases; Predictive Value of Tests; Progesterone; Ultrasonography | 1991 |
Treatment of abnormal uterine bleeding with the gynecologic resectoscope.
Topics: Adult; Aged; Amenorrhea; Antineoplastic Agents; Catheterization; Danazol; Electrocoagulation; Endometrium; Female; Humans; Hysteroscopes; Leiomyoma; Leuprolide; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Middle Aged; Uterine Neoplasms; Uterus | 1991 |
Menstrual changes associated with progestogen-only contraception.
Topics: Administration, Oral; Amenorrhea; Contraceptive Agents, Female; Counseling; Estrogens; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Norgestrel; Time Factors | 1986 |
Utilization of the biochemical response to clomiphene citrate for the selection of women with hypothalamic amenorrhea who require further investigation.
Topics: Amenorrhea; Clomiphene; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hypothalamic Diseases; Insulin; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovulation Induction; Thyrotropin-Releasing Hormone; Tomography, X-Ray Computed | 1987 |